|
|
Office Locations:
|
1 Broadway, 14th Floor
Cambridge, MA 02142
Phone: 617-531-2129
| |
|
|
|
|
|
|
Information Technology
Life Sciences & Healthcare
Manufacturing & Industrial
|
|
|
|
Headquartered in the Netherlands, DSM Venturing is an active investor in start-up companies. The firm looks for innovative products and services in Life Sciences and Materials Sciences in the fields Climate & Energy, Functionality & Performance, Health & Wellness, and Emerging Economies. DSM Venturing's mission is to explore emerging markets and technologies in order to support DSM's innovation and growth strategy. DSM Venturing participates in early and expansion stage companies or venture capital funds as a value adding partner. The firm's investments typically range between EURO 1 and EURO 20 million (no fixed upper limit), with a first investment between EURO 100k to EURO 5m. DSM's share target range in companies is 10% to 25% share. The firm currently has about EURO 60 million invested in promising companies and leading venture capital funds. DSM goes where the growth is, focusing on regions that generate the most opportunities, including China, India, Russia, and Brazil.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
